盘龙药业(002864.SZ)：酮洛芬凝胶贴膏获得药物临床试验批准通知书

Core Viewpoint - The company, Panlong Pharmaceutical (002864.SZ), has received approval from the National Medical Products Administration for clinical trials of its ketoprofen gel patch, indicating a significant step in its product development pipeline [1]. Group 1: Product Details - The ketoprofen gel patch is designed for local application, with each patch measuring 14cm x 10cm and containing 10g of gel, which includes 30mg of ketoprofen [1]. - The patch is indicated for pain relief and anti-inflammatory treatment for conditions such as osteoarthritis, periarthritis of the shoulder, tendinitis, de Quervain's tenosynovitis, lateral epicondylitis (tennis elbow), muscle pain, and swelling and pain due to trauma [1]. - The administration method involves applying one patch twice a day [1]. Group 2: Regulatory Classification - The product is classified as a Class 3 chemical drug according to registration standards [1].